KPIs & Operating Metrics(New)
Growth Metrics

Stryker (SYK) Gross Margin (2009 - 2026)

Stryker (SYK) reported Gross Margin of 63.29% for Q1 2026, down 54.0% year-over-year from 137.58% in Q1 2025, and down 1.93% on a QoQ basis from 64.54% in Q4 2025.

Stryker (SYK) has 18 years of Gross Margin data on file, last reported at 63.29% in Q1 2026.

  • Quarterly Gross Margin fell 54.0% year-over-year to 63.29% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 63.83% (down 13.0% YoY) and the FY2025 annual result came in at 63.96%, up 6.0% from the prior year.
  • Gross Margin retreated to 63.29% in Q1 2026 per SYK's latest filing, from 64.54% in the prior quarter.
  • Across five years, Gross Margin topped out at 64.85% in Q4 2024 and bottomed at 62.11% in Q3 2022.
  • The 5-year median for Gross Margin is 63.67% (2023), against an average of 63.56%.
  • The widest annual swing landed in 2022, when Gross Margin sank 257 bps; it then surged 222 bps in 2023.
  • Tracing SYK's Gross Margin over 5 years: stood at 62.21% in 2022, then climbed by 2 bps to 63.68% in 2023, then grew by 2 bps to 64.85% in 2024, then slipped by 0 bps to 64.54% in 2025, then retreated by 2 bps to 63.29% in 2026.
  • Per Business Quant, the three latest SYK Gross Margin figures stand at 63.29% (Q1 2026), 64.54% (Q4 2025), and 63.6% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 56.20%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 63.29%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 63.83%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 69.46%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 78.01%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 45.22%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 62.95%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 38.53%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 43.89%
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 72.39%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 63.29%
Dec 31, 2025 64.54%
Sep 30, 2025 63.60%
Jun 30, 2025 63.78%
Mar 31, 2025 63.83%
Dec 31, 2024 64.85%
Sep 30, 2024 64.02%
Jun 30, 2024 63.00%
Mar 31, 2024 63.57%
Dec 31, 2023 63.68%
Sep 30, 2023 64.33%
Jun 30, 2023 63.67%
Mar 31, 2023 63.12%
Dec 31, 2022 62.21%
Sep 30, 2022 62.11%
Jun 30, 2022 62.90%
Mar 31, 2022 63.95%
Dec 31, 2021 64.77%
Sep 30, 2021 63.51%
Jun 30, 2021 64.56%
Mar 31, 2021 63.47%
Dec 31, 2020 63.75%
Sep 30, 2020 65.85%
Jun 30, 2020 56.01%
Mar 31, 2020 64.97%
Dec 31, 2019 65.43%
Sep 30, 2019 64.96%
Jun 30, 2019 65.21%
Mar 31, 2019 64.93%
Dec 31, 2018 64.70%
Sep 30, 2018 66.47%
Jun 30, 2018 65.92%
Mar 31, 2018 65.94%
Dec 31, 2017 64.56%
Sep 30, 2017 66.00%
Jun 30, 2017 66.10%
Mar 31, 2017 66.46%
Dec 31, 2016 66.08%
Sep 30, 2016 66.11%
Jun 30, 2016 64.86%
Mar 31, 2016 67.90%
Dec 31, 2015 67.03%
Sep 30, 2015 67.11%
Jun 30, 2015 66.00%
Mar 31, 2015 65.28%
Dec 31, 2014 65.62%
Sep 30, 2014 65.30%
Jun 30, 2014 65.51%
Mar 31, 2014 66.33%
Dec 31, 2013 65.48%
Sep 30, 2013 68.29%
Jun 30, 2013 67.00%
Mar 31, 2013 67.44%
Dec 31, 2012 68.16%
Sep 30, 2012 68.08%
Jun 30, 2012 68.09%
Mar 31, 2012 67.19%
Dec 31, 2011 66.59%
Sep 30, 2011 67.06%
Jun 30, 2011 65.15%
Mar 31, 2011 65.81%
Dec 31, 2010 68.72%
Sep 30, 2010 69.40%
Jun 30, 2010 69.34%
Mar 31, 2010 67.65%
Dec 31, 2009 67.66%
Sep 30, 2009 67.42%
Jun 30, 2009 67.18%
Mar 31, 2009 67.81%